Pharmaceutical Industry To Push For Stricter Compulsory Licensing Of Patented Drugs At U.S. Trade Representative Meeting
Wall Street Journal: Pharma Narrowly Defines When Compulsory Licenses Should be Used
“As the U.S. Trade Representative holds a hearing [Tuesday] to discuss how countries protect intellectual property, the pharmaceutical industry hopes to persuade the agency that countries should only be allowed to grant licenses to companies to make low-cost generic drugs when there is a health emergency. That posture, however, contradicts the position taken by the World Health Organization…” (Silverman, 2/24).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.